These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 2144973

  • 21. [Pharmacologic modulation of central noradrenergic mechanisms and the effect of selected substances on chemically-induced seizures: the maximal quinolinic acid seizure test (mouse)].
    Fischer W, Ryzov IV, Lapin IP.
    Pharmazie; 1991 Apr; 46(4):301-3. PubMed ID: 1832228
    [No Abstract] [Full Text] [Related]

  • 22. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
    Harris CA, Miranda AF, Tanguay JJ, Boegman RJ, Beninger RJ, Jhamandas K.
    Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
    [Abstract] [Full Text] [Related]

  • 23. [Increase in the activity of an epileptogenic focus in frog hippocampus as a result of kynurenines and its reduction by serotonin].
    Gusel' VA, Mikhailov IB.
    Biull Eksp Biol Med; 1979 Feb; 87(2):158-60. PubMed ID: 311225
    [Abstract] [Full Text] [Related]

  • 24. Anticonvulsant effect of flutamide on seizures induced by pentylenetetrazole: involvement of benzodiazepine receptors.
    Ahmadiani A, Mandgary A, Sayyah M.
    Epilepsia; 2003 May; 44(5):629-35. PubMed ID: 12752460
    [Abstract] [Full Text] [Related]

  • 25. Taurine selectivity antagonizes L-kynurenine-produced seizures in mice.
    Lapin IP.
    J Neural Transm; 1980 May; 48(4):311-6. PubMed ID: 7420078
    [Abstract] [Full Text] [Related]

  • 26. [The neurodegenerative and convulsant action of quinolinic acid].
    Kozlovskiĭ VL, Prakh'e IV, Geĭnisman NV.
    Neirofiziologiia; 1990 May; 22(3):354-9. PubMed ID: 2144614
    [Abstract] [Full Text] [Related]

  • 27. [Enhancement of the convulsant action of strychnine following administration of kynurenines into the cerebral ventricles of frogs].
    Ryzhov IV.
    Biull Eksp Biol Med; 1980 May; 89(5):572-4. PubMed ID: 6967332
    [Abstract] [Full Text] [Related]

  • 28. [Effect of excitant amino acid antagonists on glutamate receptors in the locust and on convulsions induced by glutamate, aspartate, kynurenine and quinolinic acid in mice].
    Ryzhov IV, Slepokurov MV, Lapin IP, Mandel'shtam IuE, Aleksandrov VG.
    Biull Eksp Biol Med; 1986 Mar; 101(3):322-5. PubMed ID: 2869799
    [Abstract] [Full Text] [Related]

  • 29. Anticonvulsant drugs effective against human temporal lobe epilepsy prevent seizures but not neurotoxicity induced in rats by quinolinic acid: electroencephalographic, behavioral and histological assessments.
    Vezzani A, Wu HQ, Tullii M, Samanin R.
    J Pharmacol Exp Ther; 1986 Oct; 239(1):256-63. PubMed ID: 2945004
    [Abstract] [Full Text] [Related]

  • 30. Antagonism of kynurenine-induced seizures by picolinic, kynurenic and xanthurenic acids.
    Lapin IP.
    J Neural Transm; 1983 Oct; 56(2-3):177-85. PubMed ID: 6864208
    [Abstract] [Full Text] [Related]

  • 31. A noradrenergic component of quinolinic acid-induced seizures.
    Vezzani A, Schwarcz R.
    Exp Neurol; 1985 Oct; 90(1):254-8. PubMed ID: 2931301
    [Abstract] [Full Text] [Related]

  • 32. Norepinephrine modulates seizures induced by quinolinic acid in rats: selective and distinct roles of alpha-adrenoceptor subtypes.
    Wu HQ, Tullii M, Samanin R, Vezzani A.
    Eur J Pharmacol; 1987 Jun 26; 138(3):309-18. PubMed ID: 3040437
    [Abstract] [Full Text] [Related]

  • 33. Stimulant and convulsive effects of kynurenines injected into brain ventricles in mice.
    Lapin IP.
    J Neural Transm; 1978 Jun 26; 42(1):37-43. PubMed ID: 641543
    [Abstract] [Full Text] [Related]

  • 34. Endogenous antagonists of quinolinic acid and kynurenine as links of the defensive mechanism in epilepsy.
    Lapin IP.
    Acta Neurol (Napoli); 1985 Jun 26; 7(3-4):203-6. PubMed ID: 2932891
    [No Abstract] [Full Text] [Related]

  • 35. Quinolinic acid: effects on brain catecholamine and c-AMP content during L-dopa and reserpine administration.
    Beskid M, Finkiewicz-Murawiejska L.
    Exp Toxicol Pathol; 1992 Apr 26; 44(2):66-9. PubMed ID: 1319782
    [Abstract] [Full Text] [Related]

  • 36. [Endogenous convulsants (review)].
    Ryzhov IV, Lapin IP.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986 Apr 26; 86(1):123-31. PubMed ID: 2869628
    [No Abstract] [Full Text] [Related]

  • 37. Effect of topiramate on the anticonvulsant activity of conventional antiepileptic drugs in two models of experimental epilepsy.
    Borowicz KK, Luszczki JJ, Duda AM, Czuczwar SJ.
    Epilepsia; 2003 May 26; 44(5):640-6. PubMed ID: 12752462
    [Abstract] [Full Text] [Related]

  • 38. [The effect of catecholaminergic substances on behavior and the EEG in rats with corazole seizures].
    Avakian RM, Arushanian EB.
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1974 May 26; 24(6):1263-70. PubMed ID: 4454715
    [No Abstract] [Full Text] [Related]

  • 39. Quinolinic acid-induced seizures, but not nerve cell death, are associated with extracellular Ca2+ decrease assessed in the hippocampus by brain dialysis.
    Vezzani A, Wu HQ, Angelico P, Stasi MA, Samanin R.
    Brain Res; 1988 Jun 28; 454(1-2):289-97. PubMed ID: 2970276
    [Abstract] [Full Text] [Related]

  • 40. A peptidase-resistant cyclic octapeptide analogue of somatostatin (SMS 201-995) modulates seizures induced by quinolinic and kainic acids differently in the rat hippocampus.
    Vezzani A, Serafini R, Stasi MA, Viganò G, Rizzi M, Samanin R.
    Neuropharmacology; 1991 Apr 28; 30(4):345-52. PubMed ID: 1830135
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.